Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome (Q38193901)

30 August 2017

1 reference

title

Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome (English)

1 reference

30 August 2017

0 references

0 references

4

1 reference

30 August 2017

Y Nasser

1

1 reference

30 August 2017

G E Boeckxstaens

series ordinal

2

1 reference

30 August 2017

M M Wouters

series ordinal

3

1 reference

30 August 2017

S Vanner

series ordinal

5

1 reference

30 August 2017

publication date

14 February 2014

1 reference

Neurogastroenterology and Motility

30 August 2017

published in

1 reference

30 August 2017

volume

26

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

455-469

1 reference

Functional bowel disorders

30 August 2017

cites work

1 reference

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome

21 January 2018

1 reference

Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome

21 January 2018

1 reference

Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

21 January 2018

1 reference

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

Role for protease activity in visceral pain in irritable bowel syndrome

21 January 2018

1 reference

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

21 January 2018

1 reference

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome

21 January 2018

1 reference

Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.

21 January 2018

1 reference

Intestinal barrier function in health and gastrointestinal disease

21 January 2018

1 reference

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

21 January 2018

1 reference

Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.

21 January 2018

1 reference

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

21 January 2018

1 reference

MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome

21 January 2018

1 reference

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

21 January 2018

1 reference

The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.

21 January 2018

1 reference

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.

21 January 2018

1 reference

Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase

21 January 2018

1 reference

Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.

21 January 2018

1 reference

Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.

21 January 2018

1 reference

Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.

21 January 2018

1 reference

Bacterial proteases in IBD and IBS.

21 January 2018

1 reference

Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea

21 January 2018

1 reference

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit

21 January 2018

1 reference

Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes

21 January 2018

1 reference

SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.

21 January 2018

1 reference

Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?

21 January 2018

1 reference

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

21 January 2018

1 reference

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

21 January 2018

1 reference

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome

21 January 2018

1 reference

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome

21 January 2018

1 reference

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?

21 January 2018

1 reference

Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.

21 January 2018

1 reference

Functions and imaging of mast cell and neural axis of the gut.

21 January 2018

1 reference

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

21 January 2018

1 reference

Differential expression of toll-like receptors in patients with irritable bowel syndrome.

21 January 2018

1 reference

Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype

21 January 2018

1 reference

Review article: intestinal serotonin signalling in irritable bowel syndrome

21 January 2018

1 reference

Genetics of human gastrointestinal sensation

21 January 2018

1 reference

Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome

21 January 2018

1 reference

Serotonin transporter gene polymorphism and irritable bowel syndrome.

21 January 2018

1 reference

Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome

21 January 2018

1 reference

Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.

21 January 2018

1 reference

Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients

21 January 2018

1 reference

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

21 January 2018

1 reference

Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome

21 January 2018

1 reference

Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment

21 January 2018

1 reference

Cellular and Molecular Mechanisms of Pain

21 January 2018

1 reference

Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome

21 January 2018

1 reference

Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?

21 January 2018

1 reference

Novel functional roles for enteric glia in the gastrointestinal tract.

21 January 2018

1 reference

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome

21 January 2018

1 reference

Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NMO.12316

1 reference

30 August 2017

1 reference